US 10301292
Bicyclic compound
granted A61KA61K31/343A61K31/381
Quick answer
US patent 10301292 (Bicyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/343, A61K31/381, A61K31/416, A61K31/423